Key benefits of e-prescribing controlled substances

July 26, 2016

Better workflow efficiencies, improved patient safety and decreased drug abuse and diversion are just some of the wide-reaching benefits of electronic prescribing of controlled substances (EPCS). The U.S. Drug Enforcement Administration gave its official approval of EPCS in 2010 when the DEA revised its regulations to give practitioners the option of transmitting Schedule II-V prescriptions electronically.

Read More

Joint Commission allows texting of orders

April 28, 2016

The Joint Commission has reversed its prohibition against texting orders for patient care, treatment, or services, signaling the accreditor’s recognition of technology’s disruptive impact on healthcare—and its powerful role in care delivery. Effective immediately, prescribers may use a secure text messaging application to text such orders to the hospital or other health care settings “as long as a secure text messaging platform is used and the required components of an order are included,” the accreditor states in the May 2016 issue of its Perspectives newsletter.

Read More

How To Comply With New York I-STOP

September 1, 2015

New York providers need to be aware of the two key requirements in order to comply with coming I-STOP mandate deadlines: E-prescribing Requirement All prescriptions for both legend and controlled drugs in the state of New York must be sent electronically (e-prescribed) by March 27, 2016.

Read More

I-STOP or Not - Why Physicians Should Start E-prescribing Now

May 27, 2015

Many New York physicians feel as if they dodged a bullet on March 13th, when Governor Cuomo signed bill S2486, delaying the mandatory e-prescribing component of the I-STOP bill for one year. We now have until March 27, 2016 to comply with the law, but that deadline is closer than it appears. 

Read More

VIDEO: AHRQ Highlights Pioneer Electronic Prescribing of Controlled Substances Study

August 26, 2014

Several years ago, we embarked on a journey that no other health IT company had taken to date: we participated in a study that dramatically shifted the e-prescribing landscape by adding controlled substances as a capability. I am happy to share that the Agency for Healthcare Research and Quality (AHRQ) released a video about the three-year project.

Read More

Goodbye Dr. Mostashari

September 27, 2013

Perhaps because DrFirst is located in the Washington, DC area, and perhaps because we have a strong belief in standards and therefore participate in multiple workgroups tackling national issues, I’ve gotten to know the four individuals who have held the position as National Coordinator of Health Information Technology (ONCHIT) during their tenures–some more than others.

Read More

What’s Needed for EPCS: Critical Requirements for Providers and Vendors

September 20, 2013

For a big picture view on how controlled substance e-prescribing (EPCS) and Prescription Drug Monitoring Programs (PDMPs) will help stem the epidemic of controlled substance abuse, please see the series of blogs by my colleague Thomas Sullivan, MD. In context with that series, I thought it would be helpful to describe certain key requirements for providers pursuing controlled substance e-prescribing as mandated by the DEA.

Read More

Prescription Abandonment: It’s Not What the Doctor Ordered

November 21, 2012

Prescription abandonment is a growing concern in the medical community. With more and more doctors having digital access to patient medication history data through e-prescribing and electronic health record systems, it is becoming increasingly clear that patients never pick up prescribed medications.

Read More

Crossing the New Chasm of Electronic Prescribing of Controlled Substances (EPCS)

September 26, 2012

Back in 2001 when DrFirst first developed e-prescribing, we spent a lot of time educating providers about the benefits and patient safety advantages of utilizing technology in their practices. We spent years “Crossing the Chasm” from early adopters to broader adoption.

Read More

E-prescribing Improves Safety and Life Quality for Nursing Home and Assisted Living Patients

April 18, 2012

Adverse drug reactions (ADRs) are serious threats in nursing home and assisted living facilities where the advanced age and poor health of most patients make them more vulnerable than the general population. This effect is compounded by many patients taking multiple medications significantly increasing the possibility of an adverse event.

Read More

About the Author

Peter Kaufman CMO

Schooled at MIT, Dr. Kaufman nurtured a strong interest in medical informatics while a Bowman Gray School of Medicine faculty member. After entering private practice he founded PiNK software in 1996 to produce EMR software, later becoming DrFirst’s chief medical officer upon its founding. He lectures nationally on various healthcare IT topics, and as a board certified gastroenterologist, he continues a limited clinical practice. Dr. Kaufman is a member of the Health IT Standards Committee, Privacy and Security Workgroup for ONC (Office of the National Coordinator for Healthcare Information Technology). Representing the American Gastroenterology Association’s (AGA), Dr. Kaufman is a delegate to the AMA and was the co-chair of the Physicians Electronic Health Record Consortium (PEHRC). He has participated on workgroups at CCHIT (stand-alone e-prescribing), HIMSS (e-prescribing), and NCPDP (e-prescribing).